Metraipolis › archive › dc_bf1a02a218e7
Alpha particle therapy in glioblastoma: emerging biomarkers, mechanisms of response, and translational opportunities — Europe PMC PMID:42761776
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42761776
- DOI
- 10.3389/fonc.2026.1940181
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T03:25:29.903Z
- SHA-256 of the archived text
f6908a924045ae38225abb19202f947b327064a2c925cb12115ee1e79c418b76- Stable URL of this page
https://metraipolis.com/documento/dc_bf1a02a218e7
How to cite
Alpha particle therapy in glioblastoma: emerging biomarkers, mechanisms of response, and translational opportunities — Europe PMC PMID:42761776 — Europe PMC (en), https://europepmc.org/article/MED/42761776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf1a02a218e7 (Metraipolis archive dc_bf1a02a218e7, sha256 f6908a924045ae38225abb19202f947b327064a2c925cb12115ee1e79c418b76)
BibTeX
@misc{dcbf1a02a218e7,
title = {Alpha particle therapy in glioblastoma: emerging biomarkers, mechanisms of response, and translational opportunities — Europe PMC PMID:42761776},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42761776},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf1a02a218e7; sha256 f6908a924045ae38225abb19202f947b327064a2c925cb12115ee1e79c418b76},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42761776. Agents can read the archived copy with the MCP tool read_document.